Zelavespib (PU-H71) has been researched in trials targeting lymphomas and myeloproliferative neoplasms. This product is the DrugMonitor™ Anti-Zelavespib Antibody (VS-0125-YC2065), specifically designed as an anti-drug antibody (ADA) that targets Zelavespib. The ADA was raised in rabbits immunized with Zelavespib conjugated to BSA and is suitable for use in ELISA and lateral flow assays. This antibody may be employed in pharmacokinetics (PK) and pharmacodynamics (PD) analyses, or as a reference standard in ADA assays. Furthermore, as a drug-based antibody, it serves as an exemplary tool for therapeutic drug monitoring, facilitating the determination of Zelavespib drug concentrations in various samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for VS-0125-YC2065. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.